Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Yidu Tech, Inc. ( (HK:2158) ) just unveiled an announcement.
Yidu Tech Inc. has announced that its subsidiary EVYD Research Private Limited has secured a contract worth about SGD 2.28 million from Singapore Health Services Pte Ltd to implement and provide support and maintenance for the Dr Buddy platform. The deal marks a significant milestone in Yidu Tech’s expansion into the Singapore market, reinforcing its regional ambitions and extending the reach of its AI-powered clinical decision and precision healthcare capabilities beyond its core base in China.
By deploying its AI that models real-world disease progression and simulates physicians’ clinical decision-making, Yidu Tech aims to enhance the efficiency and accuracy of care delivery while offering more affordable precision diagnostics and treatments. The project should strengthen the company’s position as a key enabler of data-driven healthcare in Asia, potentially deepening partnerships with hospitals, pharmaceutical firms, insurers and public health authorities seeking more resilient and inclusive digital health infrastructure.
More about Yidu Tech, Inc.
Yidu Tech Inc. is a healthcare technology company specializing in AI-driven solutions that support the intelligent upgrading of China’s healthcare system. Its products focus on intelligent decision-making across healthcare services, pharmaceuticals, insurance and patients, aiming to deliver precision diagnostics, treatment support and data-driven tools to clinicians, industry players and public health systems.
Average Trading Volume: 7,147,374
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.39B
See more data about 2158 stock on TipRanks’ Stock Analysis page.